Patent Issued for Early Detectable Blood-Based Biomarker for Alzheimer’s
A U.S. patent that focuses on the development of a novel blood-based biomarker for the early detection of Alzheimer’s has been issued.
Read MorePosted by Andy Lundin | Jan 11, 2023 | Dementias & Alzheimer’s |
A U.S. patent that focuses on the development of a novel blood-based biomarker for the early detection of Alzheimer’s has been issued.
Read MorePosted by Andy Lundin | Jan 10, 2023 | Lung Cancer |
Micronoma announced its OncobiotaLUNG assay received the Breakthrough Device Designation from the U.S. FDA for lung carcinoma detection.
Read MorePosted by Andy Lundin | Jan 3, 2023 | Unknown Origin & Other Cancer Types |
The FDA granted Datar Cancer Genetics Breakthrough Device Designation for its TriNetra-Glio test, a liquid biopsy to diagnose brain tumors.
Read MorePosted by Chris Wolski | Nov 14, 2022 | Diagnostic Technologies |
Clinical laboratory experts predict continued importance on COVID testing, ongoing technician shortages, and more in 2023.
Read MorePosted by Andy Lundin | Nov 1, 2022 | Melanoma |
Proscia released study results on new AI that predicts diagnostic agreement for melanoma, the deadliest form of skin cancer.
Read More